Header Logo

Connection

Francesco Fedele to Lipopolysaccharides

This is a "connection" page, showing publications Francesco Fedele has written about Lipopolysaccharides.
Connection Strength

0.053
  1. Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. Eur J Med Chem. 2023 Sep 05; 257:115542.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.